User:Martinlebon/Quantum Surgical

Quantum Surgical is a French medical robotics company that develops robotic-assisted medical solutions for cancer treatment.

Founded in 2017, Quantum Surgical is based in [Montpellier].

The company aims to offer concrete solutions to the public health issue of cancer..

History
Quantum Surgical is a medical robotics company based in Montpellier, France. Founded in 2017, it is dedicated to developing solutions for cancer treatment. Their robotic platform, Epione®, is used for early and curative treatment of abdominal tumors in Europe and the United States.

Quantum Surgical has over 110 employees worldwide.

The company was co-founded by [Bertin Nahum] with the aim of standardizing cancer treatment, enabling more patients to benefit from targeted and less invasive therapies.

Quantum Surgical launched the Epione robot in 2020.

Epione®
Epione is a robotic-assisted system for percutaneous ablation that allows visualization, precise targeting, and direct treatment of tumors "through the skin." This minimally invasive procedure serves as an alternative to surgery for treating tumors that are particularly difficult to reach due to their size or location.

The technology ensures precision and expertise for the interventional radiologist, guiding their actions. "The robot's arm aids in the destruction of small primary or metastatic liver and primary renal tumors, minimizing damage to surrounding healthy tissues and reducing the number of images needed to guide the needle to the tumor," explains Professor Thierry de Baère, Head of Therapeutic Imaging at [Gustave Roussy].

Epione is currently dedicated to the treatment of abdominal cancers (liver, kidneys, pancreas), which account for over 4 million new cases each year globally. Quantum Surgical aims to expand Epione's applications, particularly towards lung tumors.

Epione is currently dedicated to the treatment of abdominal cancers (liver, kidneys, pancreas), which account for over 4 million new cases each year globally. Quantum Surgical aims to expand Epione's applications, particularly towards lung tumors.

As of July 2023, nearly 200 patients have been treated worldwide using Epione.

Key Dates
In September 2021, Quantum Surgical obtained the CE marking for the treatment of abdominal tumors.

In May 2022, Quantum Surgical received FDA clearance for the treatment of liver tumors in the United States..

In May 2023, the FDA clearance was expanded to cover all abdominal cancers.

Awards
In November 2022, Quantum Surgical received the [Galien USA Prize], the equivalent of the Nobel Prize in biopharmaceutical research..

External link
Official website of Quantum Surgical